Completed
Topics
New molecular and bioinformatic approaches have advanced understanding of how molecular pathways are affected by exposure and the molecular networks involved in disease. However, these advances are often not yet deemed sufficient to establish causality for public health risk assessments; regulators still rely primarily on traditional apical endpoints, such as those endpoints observed in animal studies.
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.
About
Get in touch
Our People